Multiple Sclerosis in Society and Its Effects on Individuals

Only available on StudyMode
  • Download(s) : 173
  • Published : December 6, 2010
Open Document
Text Preview
Multiple Scierosis in Society and its effects on individuals

News on multiple sclerosis
Multiple Sclerosis is a disease usually known as MS, and this affects the central nervous system- the brain and spinal cord. Multiple Sclerosis is when the nerves are not able to communicate with the body. The central nervous system has a myelin sheath covering the axons, which sends the message to the synaptic bulbs for communication to the nerves. “The myelin sheath helps the axons sends its messages rapidly, and once the myelin sheath is affected the nerves aren’t able to correspond with the body. “Multiple Sclerosis destroys the myelin sheath by putting patches causing muscle weakness and other symptoms.”Multiple Sclerosis, a spontaneous disease, can affect a person during its adult years such as the 20s, 30s, and so forth. There is not any particular race or gender that receives it more than the other merely during one’s adult age. It has also been stated that the place where one grows up at can be reason why they are diagnosed with the disease. Multiple Sclerosis treatment has generated controversy in 2010, as it does not support an etiological role of chronic cerebrospinal venous insufficiency; (Rituximab), a monoclonal antibody used to treat certain types of non-Hodgkin's lymphoma,( Alemtuzumab), is a humanized monoclonal antibody that selectively binds to CD52, a protein found on the surface of normal and malignant B and T cells, that is used to reduce the numbers of circulating malignant cells of patients who have B-cell chronic lymphocytic leukemia (B-CLL). AB,(Cladribine), The drugs used to treat cancer ultimately depend on the type of cancer and the stage of the disease. (Natalizumab), is the drugs used to treat class for the treatment ultimately depend on the type of cancer and the stage of the disease. If a drug cannot cure the alpha(4)-integrin antagonist, the first in its class for the treatment of multiple sclerosis (MS), and(...
tracking img